16815 results for "sec+and+unspecified+malignant+neoplasm"

in 19.79 milliseconds.

• sc-DECISION

  Data derived from PBMC and blood samples for the single cell and bulk RNAseq analysis for the sc-DECISION paper. https://doi.org/10.1101/2025.02.04.25321370

  Dataset EGAD50000001622

• Nanopore sequencing of AML and control samples

  Three AML samples from patients with mutations in DNMT3A, IDH2, TET2, and a control sample of whole genome amplified DNA.

  Dataset EGAD50000001692

• RNA sequencing of AVANT and CALGB trial patient samples

  Transcriptional profiling via high-throughput sequencing was performed on a set of patients from the AVANT and CALGB trials

  Dataset EGAD50000001752

• COVID-19 progression and convalescence in common variable immunodeficiency patients

  Longitudinal analysis of single-cell RNAseq datasets of PBMCs from COVID-19 CVID patients and controls.

  Dataset EGAD50000000543

• Exome sequencing of FFPE and patient-derived cultures

  Exome sequencing of FFPE and patient-derived cultures from patients enrolled in clinical study NCT03860376

  Dataset EGAD50000000245

• Transcriptome sequencing of FFPE and patient-derived cultures

  Transcriptome sequencing of FFPE and patient-derived cultures from clinical study NCT03860376

  Dataset EGAD50000000246

• Genotyping data of 81 patients with multiple sclerosis and other neurological diseases

  This dataset consists of raw unimputed genotype data for 81 individuals with multiple sclerosis (n=33) and other neurological disease (n=48).

  Dataset EGAD50000000183

• Oncotrack_450K_metastatic

  Oncotrack metastatic samples using 450K. The shared AF analysis files oncotrackDNAmAnalysis.R and oncotrackDNAmBetaScores.txt which were applied for both Oncotrack_450K_tumor (EGAD00010001162) and Oncotrack_450K_metastatic (EGAD00010001161) datasets are included on Oncotrack_450K_tumor (EGAD00010001162) dataset.

  Dataset EGAD00010001161

• Annotation file of DNA sequencing data and response

  Annotation file of DNA sequencing data of the pre-treatment biopsies in the PRADO trial and the response outcomes of the patients

  Dataset EGAD50000002547

• Gene expression from human iPSC derived cortical neurons

  Gene expression from icas9 human iPSC derived cortical neurons treated with and without doxycycline

  Study EGAS00001004782

• Expressed_fusion_transcripts_in_rare_bone_tumours

  mRNA-Seq on total RNA from primary osteoblastomas and phosphaturic mesenchymal tumours, focussing on fusion transcript expression

  Study EGAS00001000763

• Copy number profiling of pleura samples and respective tumors

  Low-coverage whole genome sequencing for the establishment of genomewide copy number alterations in pleura effusions and respective primary tumors

  Dataset EGAD00001003273

• MiSeq-High Coverage

  Seven files of patients 3, 21, 29, 30, 31, 32 and 33 with WGS done on Illumina MiSeq with high coverage. For research purpose and authorised user only.

  Dataset EGAD00001003436

• Genome - MBD4-deficient AML

  Genome sequencing at diagnosis and post induction for WEHI-AML-1 and WEHI-AML-2. Whole genome sequencing was performed on an Illumina HiSeq X Ten.

  Dataset EGAD00001003568

• Colon cancer ctDNA

  Samples prepared using Safe-SeqS technology. All samples ran on an Illumina MiSeq instrument. Fastq files for read 1 and the index read present (R and I respectively).

  Dataset EGAD00001003579

• Comparison of HCC cell lines and primary HCCs

  Whole genome sequencing (30X) using Hiseq X TEN on 4 HCC cell lines, primary HCCs and early-passage PDCs

  Dataset EGAD00001001995

• Genomic Analysis of Mucinous Tumours (GAMuT)

  Sequencing data from primary mucinous ovarian carcinomas, benign and borderline mucinous tumours and extra-ovarian mucinous metastases.

  Dataset EGAD00001004851

• Dateset of clonal evolution in myelofibrosis

  This dataset includes bam files of tumor and paired normal samples derived from 15 patients with myelofibrosis. Tumor samples includes those before and after treatment.

  Dataset EGAD00001005282

• Exome and Transcriptome for gynecologic cancer gene-drug analysis

  Total of 180 gynecologic tumor specimens were subjected for targeted-exome and/or whole-transcriptome sequencing.

  Dataset EGAD00001005331

• Whole genome sequencing and genotyping of samples from BFMOS (Mossi from Burkina faso)

  Whole genome sequencing and genotyping of samples from BFMOS (Mossi from Burkina faso)

  Dataset EGAD00001005011

• ChIP-seq for AR, FOXA1 and HOXB13 on 8 prostectomy samples

  ChIP-seq for AR, FOXA1 and HOXB13 on 8 prostectomy samples, both regions with/-out tumor cells, Fastq files.

  Dataset EGAD00001005374

• Exome and Transcriptome for gastric cancer gene-drug analysis

  Newly generated 52 gastric tumor specimens were subjected for targeted-exome and/or whole-transcriptome sequencing

  Dataset EGAD00001005766

• Sequence of breast cancer bone metastases PDX from WES

  Exome sequencing analyses obtained from 11 samples of PDX engrafted with bone metastases, match primary tumors and/or metastases and normal tissus.

  Dataset EGAD00001006071

• ALI culture bronchial cells and alveolar lung surgical resection scRNA-Seq

  ALI culture bronchial cells and alveolar lung surgical resection scRNA-Seq

  Dataset EGAD00001006185

• RNA-seq data for de-methylation of FOXP3-TSDR study

  22 RNA-seq samples of ex-vivo (TN and Treg), cultured Treg, TET1 and untreated mCherry-MOCK

  Dataset EGAD00001006865